Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Evaluation of Circulating Endothelial Cells (CECs) As Marker of Endothelial Damage in Allo-Transplanted Patients at High Risk of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS): The Cecinvod Study

Blood (2023) 142 (Supplement 1): 6786.

https://doi.org/10.1182/blood-2023-180302

Published: 2023

Journal Articles

The Impact of Different Mobilization Strategies in the Setting of Multiple Myeloma

Francesco Mazziotta, MD, Gabriele Buda, MD PhD, Nadia Cecconi, MD, Giulia Cervetti, MD, Lorenzo Iovino, MD, Enrico Orciuolo, MD PhD, Matteo Pelosini, MD PhD, Edoardo Benedetti, MD, Francesco Caracciolo, MD, Giovanni Carulli, MD, Sara Galimberti, MD PhD, Mario Petrini, MD PhD

Blood (2019) 134 (Supplement_1): 3254.

https://doi.org/10.1182/blood-2019-126118

Published: 2019

Journal Articles

Zinc Supplementation Improves T Cell Reconstitution after Allogeneic HSCT By Stimulating Endogenous Pathways of Thymic Regeneration

Lorenzo Iovino, MD, Kirsten Cooper, Sinéad Kinsella, MSc, PhD, Paul DeRoos, Reema Jain, PhD, Sara Galimberti, Enrico Orciuolo, PhD MD, Edoardo Benedetti, MD, Mario Petrini, PhD MD Prof, Jarrod A Dudakov, PhD

Blood (2018) 132 (Supplement 1): 3321.

https://doi.org/10.1182/blood-2018-99-112707

Published: 2018

Journal Articles

PET-CT Does Not Impact on the Outcome of the Patients Affected By Multiple Myeloma after Autologous Transplantation: A Real Life Experience

Walter Bertolami, MD, Paola Anna Erba, Francesco Caracciolo, Edoardo Benedetti, MD, Enrico Orciuolo, Gabriele Buda, PhD MD, Riccardo Morganti, Sara Galimberti, PhD MD, Mario Petrini, PhD MD Prof

Blood (2017) 130 (Supplement 1): 5522.

https://doi.org/10.1182/blood.V130.Suppl_1.5522.5522

Published: 2017

Journal Articles

Cytokine Release from Stimulated PBMC after-HSCT: Results of a Post-Transplant Zinc Oral Supplementation Trial (ZENITH)

Lorenzo Iovino, MD, Federico Pratesi, BD, Francesco Mazziotta, MD, Enrico Orciuolo, PhD MD, Gabriele Buda, PhD MD, Edoardo Benedetti, MD, Mario Petrini, PhD MD Prof, Paola Migliorini, PhD MD Prof, Sara Galimberti, PhD MD

Blood (2017) 130 (Supplement 1): 1017.

https://doi.org/10.1182/blood.V130.Suppl_1.1017.1017

Published: 2017

Journal Articles

Prophylaxis with ATLG Significantly Improves Chronic Graft-Versus-Host Disease / Relapse-Free Survival and Quality of Life after a Myeloablative HLA Identical Sibling Transplant for Acute Leukemia Patients in Complete Remission. Long-Term Follow-up of the Randomized ATG Familystudy

Blood (2017) 130 (Supplement 1): 519.

https://doi.org/10.1182/blood.V130.Suppl_1.519.519

Published: 2017

Journal Articles

Mini-Allogeneic Transplantation in Multiple Myeloma: A Single-Center Ten-Year Experience

Lorenzo Iovino, Enrico Orciuolo, Gabriele Buda, MD, Francesco Caracciolo, Francesco Mazziotta, Sara Galimberti, Mario Petrini, MD PhD, Edoardo Benedetti

Blood (2014) 124 (21): 5928.

https://doi.org/10.1182/blood.V124.21.5928.5928

Published: 2014

Journal Articles

Contrast Enhanced Ultrasound Sonography in Intestinal Acute Graft Versus Host Disease: Advantages of Non-Invasive Anatomic and Physiologic Measurements.

Edoardo Benedetti, Benedetto Bruno, MD, PhD, George B. McDonald, MD, Francesco Caracciolo, Federico Papineschi, Matteo Pelosini, Daniele Focosi, M.D., Sara Galimberti, Mario Petrini, MD

Blood (2009) 114 (22): 4493.

https://doi.org/10.1182/blood.V114.22.4493.4493

Published: 2009

Journal Articles

Aggressive Non Hodgkin lymphoma'patients Treated by High Dose Chemotherapy and Immunotherapy Has a Lower Relapse Rate: Results of a Computer Science Analysis.

Matteo Pelosini, M.D., Flavio Baronti, Francesco Caracciolo, Sara Galimberti, Edoardo Benedetti, Federico Papineschi, Enrico Orciuolo, Gabriele Buda, Antonina Starita, Mario Petrini, MD

Blood (2009) 114 (22): 4772.

https://doi.org/10.1182/blood.V114.22.4772.4772

Published: 2009

Journal Articles

Optimizing Follow up Schedule for Non Hodgkin Lymphoma' Patients by Multi-Objective Analysis.

Matteo Pelosini, M.D., Flavio Baronti, Francesco Caracciolo, Sara Galimberti, Edoardo Benedetti, Federico Papineschi, Enrico Orciuolo, Gabriele Buda, Antonina Starita, Mario Petrini, MD

Blood (2009) 114 (22): 3945.

https://doi.org/10.1182/blood.V114.22.3945.3945

Published: 2009

Journal Articles

The Role of Imaging in Relapse Detection During Follow up: a Fifteen-Year Single Center Experience.

Matteo Pelosini, M.D., Francesco Caracciolo, Sara Galimberti, Edoardo Benedetti, Federico Papineschi, Enrico Orciuolo, Gabriele Buda, Mario Petrini, MD

Blood (2009) 114 (22): 5007.

https://doi.org/10.1182/blood.V114.22.5007.5007

Published: 2009

Journal Articles

Early Diagnosis of Neutropenic Enterocolitis by Ultrasound Sonography.

Edoardo Benedetti, Federico Simonetti, MD, Francesco Caracciolo, Federico Papineschi, Benedetto Bruno, MD, PhD, Matteo Pelosini, Daniele Focosi, M.D., Sara Galimberti, Mario Petrini, MD

Blood (2009) 114 (22): 4742.

https://doi.org/10.1182/blood.V114.22.4742.4742

Published: 2009

Journal Articles

Nonmyeloablative allografting for newly diagnosed multiple myeloma: the experience of the Gruppo Italiano Trapianti di Midollo

Blood (2009) 113 (14): 3375–3382.

https://doi.org/10.1182/blood-2008-07-167379

Published: 2009

Journal Articles

Allogeneic nonmyeloablative hematopoietic cell transplantation in metastatic colon cancer: tumor-specific T cells directed to a tumor-associated antigen are generated in vivo during GVHD

Blood (2006) 107 (9): 3795–3803.

https://doi.org/10.1182/blood-2005-10-3945

Published: 2006

Journal Articles

In Vivo Purging with Hyper-CVAD Plus Rituximab Followed by Autologous Stem Cells Transplant and Rituximab Maintenance in Newly Diagnosed Mantle Cell Lymphoma: A Pilot Study for GISL (Italian Cooperative Study Group for Lymphoma).

Edoardo Benedetti, MD, Francesco Caracciolo, MD, Sara Galimberti, MD, Federico Papineschi, MD, Matteo Pelosini, MD, Giulia Cervetti, MD, Maido Gioacchino Castiglioni, MD, Sandra Mechelli, MD, Paola Scatena, MD, Maura Brugiatelli, MD, Mario Petrini, MD

Blood (2005) 106 (11): 5494.

https://doi.org/10.1182/blood.V106.11.5494.5494

Published: 2005

NARROW

Evaluation of Circulating Endothelial Cells (CECs) As Marker of Endothelial Damage in Allo-Transplanted Patients at High Risk of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS): The Cecinvod Study

The Impact of Different Mobilization Strategies in the Setting of Multiple Myeloma

Zinc Supplementation Improves T Cell Reconstitution after Allogeneic HSCT By Stimulating Endogenous Pathways of Thymic Regeneration

PET-CT Does Not Impact on the Outcome of the Patients Affected By Multiple Myeloma after Autologous Transplantation: A Real Life Experience

Cytokine Release from Stimulated PBMC after-HSCT: Results of a Post-Transplant Zinc Oral Supplementation Trial (ZENITH)

Prophylaxis with ATLG Significantly Improves Chronic Graft-Versus-Host Disease / Relapse-Free Survival and Quality of Life after a Myeloablative HLA Identical Sibling Transplant for Acute Leukemia Patients in Complete Remission. Long-Term Follow-up of the Randomized ATG Familystudy

Mini-Allogeneic Transplantation in Multiple Myeloma: A Single-Center Ten-Year Experience

Contrast Enhanced Ultrasound Sonography in Intestinal Acute Graft Versus Host Disease: Advantages of Non-Invasive Anatomic and Physiologic Measurements.

Aggressive Non Hodgkin lymphoma'patients Treated by High Dose Chemotherapy and Immunotherapy Has a Lower Relapse Rate: Results of a Computer Science Analysis.

Optimizing Follow up Schedule for Non Hodgkin Lymphoma' Patients by Multi-Objective Analysis.

The Role of Imaging in Relapse Detection During Follow up: a Fifteen-Year Single Center Experience.

Early Diagnosis of Neutropenic Enterocolitis by Ultrasound Sonography.

Nonmyeloablative allografting for newly diagnosed multiple myeloma: the experience of the Gruppo Italiano Trapianti di Midollo

Allogeneic nonmyeloablative hematopoietic cell transplantation in metastatic colon cancer: tumor-specific T cells directed to a tumor-associated antigen are generated in vivo during GVHD

In Vivo Purging with Hyper-CVAD Plus Rituximab Followed by Autologous Stem Cells Transplant and Rituximab Maintenance in Newly Diagnosed Mantle Cell Lymphoma: A Pilot Study for GISL (Italian Cooperative Study Group for Lymphoma).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only